Brain zaps tailored to each patient may tame Alzheimer's agitation

NCT ID NCT07692542

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether a personalized form of transcranial magnetic stimulation (TMS) can safely reduce behavioral and psychological symptoms in people with Alzheimer's disease. Participants receive either real or sham TMS guided by their own brain network maps. The goal is to see if this targeted approach can ease symptoms like agitation and mood changes without medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial magnetic stimulation (TMS)
What this could lead to
If it works, this could offer a non-drug way to reduce troubling behavioral symptoms in Alzheimer's patients, potentially improving their daily life and easing caregiver burden.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply widely. TMS is generally safe but can cause headache or scalp discomfort, and its effectiveness for these symptoms is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Anhui Medical University

    Hefei, Anhui, 230000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.